FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309144601> ?p ?o ?g. }

• W4309144601 endingPage "162" @default.
• W4309144601 startingPage "151" @default.
• W4309144601 abstract "Extracorporeal membrane oxygenation (ECMO) has been widely used in patients with COVID-19, but uncertainty remains about the determinants of in-hospital mortality and data on post-discharge outcomes are scarce. The aims of this study were to investigate the variables associated with in-hospital outcomes in patients who received ECMO during the first wave of COVID-19 and to describe the status of patients 6 months after ECMO initiation.EuroECMO-COVID is a prospective, multicentre, observational study developed by the European Extracorporeal Life Support Organization. This study was based on data from patients aged 16 years or older who received ECMO support for refractory COVID-19 during the first wave of the pandemic-from March 1 to Sept 13, 2020-at 133 centres in 21 countries. In-hospital mortality and mortality 6 months after ECMO initiation were the primary outcomes. Mixed-Cox proportional hazards models were used to investigate associations between patient and management-related variables (eg, patient demographics, comorbidities, pre-ECMO status, and ECMO characteristics and complications) and in-hospital deaths. Survival status at 6 months was established through patient contact or institutional charts review. This study is registered with ClinicalTrials.gov, NCT04366921, and is ongoing.Between March 1 and Sept 13, 2020, 1215 patients (942 [78%] men and 267 [22%] women; median age 53 years [IQR 46-60]) were included in the study. Median ECMO duration was 15 days (IQR 8-27). 602 (50%) of 1215 patients died in hospital, and 852 (74%) patients had at least one complication. Multiorgan failure was the leading cause of death (192 [36%] of 528 patients who died with available data). In mixed-Cox analyses, age of 60 years or older, use of inotropes and vasopressors before ECMO initiation, chronic renal failure, and time from intubation to ECMO initiation of 4 days or more were associated with higher in-hospital mortality. 613 patients did not die in hospital, and 547 (95%) of 577 patients for whom data were available were alive at 6 months. 102 (24%) of 431 patients had returned to full-time work at 6 months, and 57 (13%) of 428 patients had returned to part-time work. At 6 months, respiratory rehabilitation was required in 88 (17%) of 522 patients with available data, and the most common residual symptoms included dyspnoea (185 [35%] of 523 patients) and cardiac (52 [10%] of 514 patients) or neurocognitive (66 [13%] of 512 patients) symptoms.Patient's age, timing of cannulation (<4 days vs ≥4 days from intubation), and use of inotropes and vasopressors are essential factors to consider when analysing the outcomes of patients receiving ECMO for COVID-19. Despite post-discharge survival being favourable, persisting long-term symptoms suggest that dedicated post-ECMO follow-up programmes are required.None." @default.
• W4309144601 created "2022-11-23" @default.
• W4309144601 creator A5000009072 @default.
• W4309144601 creator A5000040132 @default.
• W4309144601 creator A5000153449 @default.
• W4309144601 creator A5000397597 @default.
• W4309144601 creator A5000529499 @default.
• W4309144601 creator A5000683754 @default.
• W4309144601 creator A5000935889 @default.
• W4309144601 creator A5001017945 @default.
• W4309144601 creator A5001355475 @default.
• W4309144601 creator A5001976899 @default.
• W4309144601 creator A5002143975 @default.
• W4309144601 creator A5002501152 @default.
• W4309144601 creator A5002725370 @default.
• W4309144601 creator A5003168632 @default.
• W4309144601 creator A5003413287 @default.
• W4309144601 creator A5003564467 @default.
• W4309144601 creator A5003648498 @default.
• W4309144601 creator A5003882967 @default.
• W4309144601 creator A5004252946 @default.
• W4309144601 creator A5004558936 @default.
• W4309144601 creator A5004579951 @default.
• W4309144601 creator A5004595193 @default.
• W4309144601 creator A5005085926 @default.
• W4309144601 creator A5005314227 @default.
• W4309144601 creator A5005380031 @default.
• W4309144601 creator A5005402426 @default.
• W4309144601 creator A5005446581 @default.
• W4309144601 creator A5005521386 @default.
• W4309144601 creator A5005592291 @default.
• W4309144601 creator A5006221152 @default.
• W4309144601 creator A5006530897 @default.
• W4309144601 creator A5006786702 @default.
• W4309144601 creator A5006809038 @default.
• W4309144601 creator A5006813747 @default.
• W4309144601 creator A5006966318 @default.
• W4309144601 creator A5006992434 @default.
• W4309144601 creator A5007060031 @default.
• W4309144601 creator A5007404096 @default.
• W4309144601 creator A5007850230 @default.
• W4309144601 creator A5007875188 @default.
• W4309144601 creator A5007984532 @default.
• W4309144601 creator A5008051289 @default.
• W4309144601 creator A5008172067 @default.
• W4309144601 creator A5008173624 @default.
• W4309144601 creator A5008317690 @default.
• W4309144601 creator A5008783461 @default.
• W4309144601 creator A5008896664 @default.
• W4309144601 creator A5008923457 @default.
• W4309144601 creator A5009036367 @default.
• W4309144601 creator A5009225569 @default.
• W4309144601 creator A5009282097 @default.
• W4309144601 creator A5009534264 @default.
• W4309144601 creator A5009556038 @default.
• W4309144601 creator A5009617397 @default.
• W4309144601 creator A5009764901 @default.
• W4309144601 creator A5010285758 @default.
• W4309144601 creator A5010319817 @default.
• W4309144601 creator A5010506546 @default.
• W4309144601 creator A5010576826 @default.
• W4309144601 creator A5010850499 @default.
• W4309144601 creator A5011456617 @default.
• W4309144601 creator A5011591683 @default.
• W4309144601 creator A5012025795 @default.
• W4309144601 creator A5012226854 @default.
• W4309144601 creator A5012504719 @default.
• W4309144601 creator A5012631532 @default.
• W4309144601 creator A5012754771 @default.
• W4309144601 creator A5012942242 @default.
• W4309144601 creator A5013768309 @default.
• W4309144601 creator A5013786787 @default.
• W4309144601 creator A5014183616 @default.
• W4309144601 creator A5014244317 @default.
• W4309144601 creator A5014307741 @default.
• W4309144601 creator A5014436829 @default.
• W4309144601 creator A5014705369 @default.
• W4309144601 creator A5014873024 @default.
• W4309144601 creator A5015020536 @default.
• W4309144601 creator A5015265487 @default.
• W4309144601 creator A5015299354 @default.
• W4309144601 creator A5015352328 @default.
• W4309144601 creator A5015582790 @default.
• W4309144601 creator A5015589733 @default.
• W4309144601 creator A5015655934 @default.
• W4309144601 creator A5015742759 @default.
• W4309144601 creator A5015921189 @default.
• W4309144601 creator A5016147364 @default.
• W4309144601 creator A5016246504 @default.
• W4309144601 creator A5016545357 @default.
• W4309144601 creator A5016557420 @default.
• W4309144601 creator A5016595797 @default.
• W4309144601 creator A5016802847 @default.
• W4309144601 creator A5016891339 @default.
• W4309144601 creator A5017027645 @default.
• W4309144601 creator A5017031744 @default.
• W4309144601 creator A5017044507 @default.
• W4309144601 creator A5017237575 @default.

• next